Tredegar Updates on Brazilian Merger Review for Terphane Sale to Oben Group

TREDEGAR CORP

SG-CADE issued a non-binding opinion on May 13, 2024 recommending rejection of the Terphane sale to Oben Group.
The case now moves to the CADE Tribunal for final review, with a maximum deadline of November 18, 2024.
Tredegar CEO John Steitz expressed confidence in the transaction's positive impact on the Brazilian flexible packaging market.
The SG opinion is non-binding; the CADE Tribunal will conduct an independent analysis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.